The third annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2018 will take place February 1-3 at the Hilton San Diego Bayfront in San Diego, California.

Themed “Therapeutic Targets in MS: The Frontier and the Future of Disease Modifying Therapy,” this CME accredited meeting stands apart from many traditional medical meetings by offering a singular track of scientific and clinical presentations in an interactive environment, as well as numerous networking opportunities. Highlights of the Forum include the Kenneth P. Johnson Memorial Lecture and the National Multiple Sclerosis Society Barancik Award presentation and talk. In addition, two poster sessions will showcase approximately 200 posters.

ACTRIMS is committed to fostering the careers of young investigators with an interest in MS. The first session of the Forum is composed of platform presentations by young investigators who will be selected based on a review of the submitted abstracts.  In addition, junior faculty, fellows and students who submit abstracts are eligible for an education grant to support their attendance.  Neurologists in training will learn about career paths in clinical and investigative neuroimmunology through the pre-conference event, "Neurology Resident Summit in Multiple Sclerosis."

ACTRIMS Forum 2018 will provide an excellent opportunity to interact with scientists and clinicians at the cutting edge of MS research. The inaugural ACTRIMS Forum, held in New Orleans in February 2016, was a great success with over 600 participants, well surpassing the original projected attendance of 250. 2017 was a record-breaking year with over 800 attendees. Approximately 1,000 attendees are expected in 2018 as ACTRIMS continues to further its mission of providing leadership in the field of multiple sclerosis and other demyelinating diseases.